Pipelines
More than 1,500 healthcare, agrifood and industrial products in development highlight the great potential of the Spanish biotechnology sector.
At AseBio, we compile all the research and development of healthcare products (medicines, diagnostic products, research platforms and other technologies), agri-food products (ingredients, additives and probiotics, products for food safety and detection of substances, bioproducts, bioprocesses and technologies , veterinary feed and medicines) and industrial products (bioprocesses, bioproducts, technologies and biofuels) made by our associates.
Plus, we include the development phase for each case and its various indications or applications. Each pipeline has a search engine to make it easy to find studies, development phases or companies.
Biotech Sanitaria
| Nombre socio | Producto / Servicio | Tipo | Therapeutic area | Propiedades/Indicación | Fase de desarrollo |
|---|---|---|---|---|---|
| Laminar Pharma | LAMPEC11 | Biodrugs/ Drugs | Oncología | Brain cancer | R&D |
| Laminar Pharma | LAMAC2 | Biodrugs/ Drugs | Enfermedades infecciosas | Respiratory infections | P I |
| Laminar Pharma | LAM561 | Biodrugs/ Drugs | Oncología | Glioma and other solid tumours | P III |
| Laminar Pharma | LAM226A1 | Biodrugs/ Drugs | Sistema nervioso central | Alzheimer's Disease | Preclinical |
| Laminar Pharma | LAM182 | Biodrugs/ Drugs | Oncología | Pancreas | P II |
| Laminar Pharma | LAM181 | Biodrugs/ Drugs | Sistema nervioso central | Spinal Cord Injury, Pain. Global rigths outlicensed to a third party biotech company | P II |
| Laminar Pharma | LAM30171 | Biodrugs/ Drugs | Oncología, Trastornos metabólicos / Endocrinología | Metabolic Diseases, cancer | R&D |
| Laminar Pharma | LAM204A1 | Biodrugs/ Drugs | Inmunología, Enfermedades cardiovasculares y sistema circulatorio | Inflammation, Cardiovascular | R&D |
| Laminar Pharma | LAM205A1 | Biodrugs/ Drugs | Enfermedades cardiovasculares y sistema circulatorio, Sistema nervioso central, Trastornos metabólicos / Endocrinología | Cardiovascular and Metabolic Diseases, CNS, | R&D |
| Nombre socio | Producto / Servicio | Tipo | Propiedades/Indicación | Fase de desarrollo |
|---|---|---|---|---|
| Laminar Pharma | Membrane-Lipid Therapy (MLT) | Enabling Technologies | Membrane-Lipid Therapy (MLT), a novel therapeutic approach targeting lipid metabolism | Clinical Validation |